Sanjula Jain-Nagpal
Sanjula Jain-Nagpal is a close adviser to FDA Commissioner Marty Makary, who recently faced scrutiny over her representation as the new deputy chief of staff before official approval was granted. Her role and the ensuing controversy contribute to the ongoing challenges facing the FDA's leadership.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 5.00 | 0.05% | +0% | 331,002,651 | 152,325 | $21,000,000 | 9,664$ |
| Totals | 1 | 331,002,651 | 152,325 | $21,000,000 | 9,664$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Sanjula Jain-Nagpal represented herself to some FDA stakeholders as the commissioner’s new deputy chief of staff.
5